** Charlton Morris, Exclusive Search Partner for Synthego Corporation **
Charlton Morris are excited to announce an exclusive recruitment project with Synthego Corporation, a pioneering Biotech providing powerful genome engineering solutions across Engineered Cell Lines, CRISPR-Cas9 kits & libraries and Bioinformatic platforms, to hire several Strategic Account Managers and establish their European commercial force. This one is for the North UK & Nordic region.
The company pride themselves in providing a complete array of cost-efficient solutions, that enable the highest precision and reliability in genome editing on the market; recognised by prestigious institutes and industry leaders globally!
Here’s a link to their website for quick review:
Founded in 2012 by technical entrepreneurs in Silicon Valley, including co-inventor of ‘CRISPR’ itself Jennifer Doudna on the advisory board, they have delivered Year on Year growth at 3.5X, and have raised a healthy $160M in Series C funding, and are now searching for someone equally passionate about the CRISPR-Cas9 revolution with a proven commercial track record in driving the uptake of novel/disruptive technologies and products into Bioproduction, Stem Cell Research, Cell & Gene Therapy related accounts.
Reporting into the European Commercial Leader, you will work home officed anywhere in North UK, Sweden or Denmark, possess domain expertise in gene engineering, stem cell media or cell line bioproduction and showcase credentials in driving high digit growth across pharmaceutical, biotechnology and academic customers.
What can you expect in this role?
What can Synthego offer YOU in return?
If you satisfy the above criteria, please attach a tailored CV and cover letter for consideration ASAP as this position won't be open for long!